Correlation Between Dr Reddys and TG Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and TG Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and TG Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and TG Therapeutics, you can compare the effects of market volatilities on Dr Reddys and TG Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of TG Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and TG Therapeutics.
Diversification Opportunities for Dr Reddys and TG Therapeutics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between RDY and TGTX is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and TG Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TG Therapeutics and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with TG Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TG Therapeutics has no effect on the direction of Dr Reddys i.e., Dr Reddys and TG Therapeutics go up and down completely randomly.
Pair Corralation between Dr Reddys and TG Therapeutics
Considering the 90-day investment horizon Dr Reddys is expected to generate 2.31 times less return on investment than TG Therapeutics. But when comparing it to its historical volatility, Dr Reddys Laboratories is 4.08 times less risky than TG Therapeutics. It trades about 0.07 of its potential returns per unit of risk. TG Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 2,898 in TG Therapeutics on August 31, 2024 and sell it today you would earn a total of 582.00 from holding TG Therapeutics or generate 20.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Dr Reddys Laboratories vs. TG Therapeutics
Performance |
Timeline |
Dr Reddys Laboratories |
TG Therapeutics |
Dr Reddys and TG Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dr Reddys and TG Therapeutics
The main advantage of trading using opposite Dr Reddys and TG Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, TG Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TG Therapeutics will offset losses from the drop in TG Therapeutics' long position.The idea behind Dr Reddys Laboratories and TG Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |